This could happen if the treatment and control groups are not comparable- for example if doctors prescribed GLP-1s vs another diabetes medication for systematic reasons such as the health profile of the patient
Vyvanse also has a black box warning, which is the strongest warning required by the FDA
Of note, all the studies undertaken in the OCC included in this meta-analysis used 3 T MRS strength, whereas there was variation in MRS strength across the other brain regions (7 T was used for two MFC studies, with 3 T used for three MFC studies)
However, while semaglutide can be effective, it may not be the most cost-effective long-term option compared to endoscopic sleeve gastroplasty (ESG)
Patients should not use tirzepatide if the solution exhibits: Pink, red, or brown coloration throughout the solution Cloudiness, haziness, or loss of clarity Visible particles, crystals, or floating material Discoloration present in an unopened, unused auto-injector Any appearance that is not clear and colorless to slightly yellow These findings suggest chemical degradation, contamination, or product defect that may compromise both safety and efficacy
The Ozempic litigation primarily argues failure to warn